Evidence check: Triglyceride in the context of fertility

Triglycerides are blood lipids that play a moderately supported role in fertility. Elevated triglyceride levels are commonly observed in women with PCOS (polycystic ovary syndrome) and metabolic syndrome, both of which can impair female fertility. In men, some observational studies suggest an association between high triglycerides and reduced sperm quality (motility, morphology). The evidence comes mainly from epidemiological and clinical studies, not from large randomized controlled trials. Genetic predispositions (e.g., variants in APOA1 or other lipid genes) can influence triglyceride levels, but the effect is usually small and overshadowed by lifestyle factors (diet, exercise, weight). A DNA test like MyBody-X can identify risk variants, but a genetic statement alone is insufficient for fertility assessment. Measuring triglycerides in blood (e.g., as part of a fasting lipid panel) is clinically established, but the fertility context should always be considered holistically. Caveat: Single biomarkers or gene variants are not diagnostic for fertility disorders. The evidence level is moderate.